Antisense MBD2 gene therapy inhibits tumorigenesis

Journal of Gene Medicine

Volumn 4, Issue 4, 2002, Pages 381-389

  Slack, Andrew ^a   Bovenzi, Veronica ^a   Bigey, Pascal ^b   Ivanov, M A ^b   Ramchandani, Shyam ^a   Bhattacharya, Sanjoy ^a   tenOever, Benjamin ^a   Lamrihi, B ^b   Scherman, Daniel ^b   Szyf, Moshe ^a  

^a MCGILL UNIVERSITY   (Canada)

^b SANOFI   (France)

Author keywords

Adenoviral vectors; Antisense; Demethylase; DNA methylation; Methylated DNA binding proteins; Tumorigenesis

Indexed keywords

ADENOVIRUS VECTOR; DNA BINDING PROTEIN; METHYL CPG BINDING PROTEIN 2; COMPLEMENTARY DNA;

ADENOVIRUS; ANCHORAGE INDEPENDENT GROWTH; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER INHIBITION; CARCINOGENESIS; CONTROLLED STUDY; DNA METHYLATION; DRUG POTENCY; ELECTROTRANSFORMATION; EMBRYO; EX VIVO STUDY; GENE REPRESSION; GENE TARGETING; GENE THERAPY; GENETIC REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VIVO STUDY; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; TUMOR XENOGRAFT; VIRAL GENE DELIVERY SYSTEM; EXPERIMENTAL NEOPLASM; GENE VECTOR; GENETICS; LUNG NON SMALL CELL CANCER; LUNG TUMOR;

ADENOVIRIDAE; CARCINOMA, NON-SMALL-CELL LUNG; DNA METHYLATION; DNA, ANTISENSE; DNA-BINDING PROTEINS; GENE THERAPY; GENETIC VECTORS; HUMANS; LUNG NEOPLASMS; NEOPLASMS, EXPERIMENTAL;

EID: 13644255586     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jgm.288     Document Type: Article

References (40)

1. Razin A, Szyf M. DNA methylation patterns. Formation and function. Biochim Biophys Acta 1984; 782: 331-342.
2. Razin A, Cedar H. Distribution of 5-methylcytosine in chromatin. Proc Natl Acad Sci U S A 1977; 74: 2725-2728.
3. Razin A, Riggs AD. DNA methylation and gene function. Science 1980; 210: 604-610.
4. Razin A. CpG methylation, chromatin structure and gene silencing: a three-way connection. Embo J 1998; 17: 4905-4908.
5. Baylin SB, Herman JG, Graff JR, et al. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 1998; 72: 141-196.
6. Baylin SB. Abnormal regional hypermethylation in cancer cells. AIDS Res Hum Retroviruses 1992; 8: 811-820.
7. Feinberg AP, Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 1983; 301: 89-92.
8. Szyf M. DNA methylation properties: consequences for pharmacology. Trends Pharmacol Sci 1994; 15: 233-238.
9. Robertson KD, Uzvolgyi E, Liang G, et al. The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res 1999; 27: 2291-2298.
10. Weiss A, Cedar H. The role of DNA demethylation during development. Genes Cells 1997; 2: 481-486.
11. Jost JP, Siegmann M, Sun L, et al. Mechanisms of DNA demethylation in chicken embryos. Purification and properties of a 5-methylcytosine-DNA glycosylase. J Biol Chem 1995; 270: 9734-9739.
12. Ramchandani S, Bhattacharya SK, Cervoni N, et al. DNA methylation is a reversible biological signal [see comments]. Proc Natl Acad Sci U S A 1999; 96: 6107-6112.
13. Hendrich B, Bird A. Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol Cell Biol 1998; 18: 6538-6547.
14. MacLeod AR, Szyf M. Expression of antisense to DNA methyltransferase mRNA induces DNA demethylation and inhibits tumorigenesis. J Biol Chem 1995; 270: 8037-8043.
15. Laird PW, Jackson-Grusby L, Fazeli A, et al. Suppression of intestinal neoplasia by DNA hypomethylation. Cell 1995; 81: 197-205.
16. Ramchandani S, MacLeod AR, Pinard M, et al. Inhibition of tumorigenesis by a cytosine-DNA, methyltransferase, antisense oligodeoxynucleotide. Proc Natl Acad Sci U S A 1997; 94: 684-689.
17. Szyf M. Targeting DNA methyltransferase in cancer. Cancer Metastasis Rev 1998; 17: 219-231.
18. Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 2000; 16: 168-174.
19. Meehan RR, Lewis JD, Bird AP. Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA. Nucleic Acids Res 1992; 20: 5085-5092.
20. Lewis JD, Meehan RR, Henzel WJ, et al. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell 1992; 69: 905-914.
21. Cross SH, Meehan RR, Nan X, et al. A component of the transcriptional repressor MeCP1 shares a motif with DNA methyltransferase and HRX proteins. Nat Genet 1997; 16: 256-259.
22. Nan X, Ng HH, Johnson CA, et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex [see comments]. Nature 1998; 393: 386-389.
23. Jones PL, Veenstra GJ, Wade PA, et al. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet 1998; 19: 187-191.
24. Ng HH, Zhang Y, Hendrich B, et al. MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex [see comments]. Nat Genet 1999; 23: 58-61.
25. Ng HH, Jeppesen P, Bird A. Active repression of methylated genes by the chromosomal protein MBD1. Mol Cell Biol 2000; 20 1394-1406.
26. Boeke J, Ammerpohl O, Kegel S, et al. The minimal repression domain of MBD2b overlaps with the methyl-CpG binding domain and binds directly to Sin3A. J Biol Chem 2000; 275: 34963-34967.
27. Wade PA, Gegonne A, Jones PL, et al. Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation [see comments]. Nat Genet 1999; 23: 62-66.
28. Bhattacharya SK, Ramchandani S, Cervoni N, et al. A mammalian protein with specific demethylase activity for mCpG DNA. Nature 1999; 397: 579-583.
29. Vilain A, Vogt N, Dutrillaux B, et al. DNA methylation and chromosome instability in breast cancer cell lines. FEBS Lett 1999; 460: 231-234.
30. Hattori M, Sakamoto H, Satoh K, et al. DNA demethylase is expressed in ovarian cancers and the expression correlates with demethylation of CpG sites in the promoter region of c-erbB-2 and surviving genes. Cancer Lett 2001; 169: 155-164.
31. Kanai Y, Ushijima S, Nakanishi Y, et al. Reduced mRNA expression of the DNA demethylase, MBD2, in human colorectal and stomach cancers. Biochem Biophys Res Commun 1999; 264: 962-966.
32. Saito KY, Sakamoto M, Saito H, Ishii H, Hirohashi S. Expression of mRNA for DNA methyltransferases and methyl-CpG-binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis. Hepatology 2001; 33: 561-568.
33. Ausubel FM, Brent R, Kingston RE, et al. Current Protocols in Molecular Biology. John Wiley: New York, 1988.
34. Szyf M, Milstone DS, Schimmer BP, et al. cis-Modification of the steroid 21-hydroxylase gene prevents its expression in the Y1 mouse adrenocortical tumor cell line. Mol Endocrinol 1990; 4: 1144-1152.
35. He TC, Zhou S, da Costa LT, et al. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 1998; 95: 2509-2514.
36. Knox JD, Araujo FD, Bigey P, et al. Inhibition of DNA methyltransferase inhibits DNA replication. J Biol Chem 2000; 275: 17986-17990.
37. Slack A, Cervoni N, Pinard M, et al. DNA methyltransferase is a downstream effector of cellular transformation triggered by simian virus 40 large T antigen. J Biol Chem 1999; 274: 10105-10112.
38. Mohan LS, Mohanam S, Kin Y, Sawaya R, Kyritsis AP, Nicolson GL, Rao JS. Downregulation of the urokinase-type plasminogen activator receptor through inhibition of translation by antisense oligonucleotide suppresses invasion of human glioblastoma cells. Clin Exp Metastasis 1999; 17: 617-621.
39. Mir OS. Mechanisms of electrochemotherapy. Adv Drug Deliv Rev 1999; 35: 107-118.
40. Freedman VH, Shin S. Cellular tumorigenicity in nude mice: correlation with cell growth and semi-solid medium. Cell 1974; 3 355-359.